Select your Language: हिन्दी
India

India’s Corona Vaccine: Phase-III Trial of Covaxin Begin in UP’s Lucknow, Gorakhpur from October

The company plans to test the vaccine on about 25,000 – 30,000 people in phase -3.

In a piece of hopeful news, the Uttar Pradesh government on Thursday announced that Phase-III trials of the corona virus (COVID-19) vaccine ‘COVAXIN’ will start in Lucknow and Gorakhpur from October.

The phase-3 trial of COVAXIN being developed by Bharat Biotech will start in Lucknow and Gorakhpur from October, said Uttar Pradesh Principal Health Secretary Amit Mohan Prasad in a press conference.

The company plans to test the vaccine on about 25,000 – 30,000 people in phase -3.
Notably, the Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.

Related Articles

Back to top button